Document Detail


The impact of postoperative infliximab maintenance therapy on preventing the surgical recurrence of Crohn's disease: a single-center paired case-control study.
MedLine Citation:
PMID:  23463537     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
PURPOSE: Preventing a recurrence of Crohn's disease is a problem that remains to be solved. We evaluated the impact of using infliximab as a postoperative therapy on preventing the surgical recurrence of Crohn's disease. METHODS: We performed a pair-matched study comparing 100 patients who had received postoperative infliximab maintenance therapy with those who had not between 1995 and 2010. The patients were matched by gender, Vienna classification and age at the time of the operation. Crohn's disease-related reoperation was evaluated as surgical recurrence. RESULTS: In the postoperative infliximab maintenance therapy group, infliximab was administrated within 8 weeks after the operation. The median follow-up period was 36 months in the postoperative infliximab maintenance therapy group and 51 months in the control group. Surgical recurrences were recognized in 37 patients (three in the postoperative infliximab maintenance therapy group and 34 in the control group). A univariate analysis by the Kaplan-Meier method identified a body mass index >18 at the time of the operation (HR 0.19, p = 0.01) and postoperative infliximab maintenance therapy (HR 0.22, p = 0.0022) as factors related to the reduction of surgical recurrence. The multivariate analysis revealed that postoperative infliximab maintenance therapy was the only significant factor preventing surgical recurrence. CONCLUSION: Postoperative infliximab maintenance therapy for Crohn's disease prevents surgical recurrence, at least within 3 years after the operation.
Authors:
Toshimitsu Araki; Keiichi Uchida; Yoshiki Okita; Hiroyuki Fujikawa; Mikihiro Inoue; Masaki Ohi; Koji Tanaka; Yasuhiro Inoue; Yasuhiko Mohri; Masato Kusunoki
Related Documents :
23941857 - Triple antithrombotic therapy is the independent predictor for the occurrence of major ...
25006277 - Importance of early and deeper responses to long-term survival in cml patients: implica...
8409547 - Clinical assessment following coronary revascularization.
24320947 - Thrombolytic therapy with intravenous recombinant tissue plasminogen activator in japan...
20583207 - Persistence with cholinesterase inhibitor therapy in a population-based cohort of patie...
23882687 - Polychromatic angiography for the assessment of vegf induced brb dysfunction in the rab...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-3-6
Journal Detail:
Title:  Surgery today     Volume:  -     ISSN:  1436-2813     ISO Abbreviation:  Surg. Today     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-3-6     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9204360     Medline TA:  Surg Today     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Division of Reparative Medicine, Department of Gastrointestinal and Pediatric Surgery, Institute of Life Sciences Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan, taraki@clin.medic.mie-u.ac.jp.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Laparoscopic gastrectomy for patients with a history of upper abdominal surgery: results of a matche...
Next Document:  Intraoperative thrombectomy for occluded carotid arteries in patients with acute aortic dissection: ...